Secondly, there is mounting evidence that IgM ELISA maybe more sensitive in identifying infection early on in the course of illness, which will provide a definite advantage to the treating clinician to prioritize healthcare resources in a timely manner. The gene discussed is CD40LG; the disease is infection.